That matters most when something falls outside expectation and the business has to decide what happens next. In tablet and capsule manufacture, weight variability is one
of the situations that brings that issue into sharp focus.
At that point, the question is not simply whether variation exists. The real question is whether the organisation has enough evidence, enough control, and enough decision discipline to
judge what that variation means and respond appropriately. Should the batch be rejected? Should it be contained pending further review? Is recovery possible in a controlled and
defensible way? Those are not narrow technical questions. They are business-critical decisions with implications for quality, cost, supply, and credibility.
Too often, businesses still handle them badly. Some default to rejection because confidence is weak and the route to a more precise decision is unclear. Others lean too quickly toward
recovery because the cost of scrap is uncomfortable. Neither response is strong enough on its own. The issue is not whether the business is cautious or commercially driven. The issue is whether the decision is properly supported.
For senior leaders across OSD manufacturing, R&D, quality, and operations, this deserves more attention than it usually gets. A poor batch disposition decision can destroy value unnecessarily or create avoidable risk that resurfaces later through deviation review, inspection, or customer challenge. A good one protects quality without writing off product simply because the organisation lacked the means to judge it properly.
This article looks at how weight variability should be approached as a batch decision problem, not just a process event, and what stronger recovery-versus-rejection thinking looks like in practice.
Download the full article here
